To Deflect Impending Patent Suit, Digene Files Pre-emptive Court Strike Against Enzo Biochem | GenomeWeb

NEW YORK, March 18 - Diagnostics company Digene filed suit against Enzo Biochem on Friday seeking to free itself from patent claims that Enzo might make against its gene-based pathogen detection kits.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.